Article · 24 Jan 2024
Conference abstractPublished 2016
The oxidative stress initiated mitochondrial DNA over proliferation and deletion in the context of the cancer and neurodegeneration: Recent challenge in neuropharmacology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It has been postulated that Alzheimer disease (AD) and cancer are systemic process, which involves multiple pathophysiological factors. Nitric oxide- (NO-) dependent oxidative stress appeared to be key pathway that results in mitochondrial ultrastructural alterations and DNA damage in cases of Alzheimer disease (AD) and may be in other pathology. However, little is known about these pathways in human cancers, especially during the development as well as the progression of primary brain tumors and metastatic colorectal cancer. One of the key features of tumors is the deficiency in tissue energy that accompanies mitochondrial lesions and formation of the hypoxic smaller sized mitochondria with ultrastructural abnormalities. We theorize that mitochondrial involvement may play a significant role in the etiopathogenesis of cancer. Recent studies also demonstrate a potential link between AD and cancer, and anticancer drugs are being explored for the inhibition of AD-like pathology in transgenic mice. Severity of the cancer growth, metastasis, and brain pathology in AD (in animal models that mimic human AD) correlate with the degree of mitochondrial ultrastructural abnormalities. Recent advances in the cell-cycle reentry of the terminally differentiated neuronal cells indicate that NO-dependent mitochondrial abnormal activities and mitotic cell division are not the only important pathogenic factors in pathogenesis of cancer and AD, but open a new window for the development of novel more specific and target based treatment strategies at least for these devastating diseases.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neuroscience and Neuropharmacology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroscience and Neuropharmacology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Gjumrakch Aliev”
